Overview
Lhermitte-Duclos disease (LDD), also known as dysplastic gangliocytoma of the cerebellum or Cowden syndrome with cerebellar involvement, is a rare condition that causes an abnormal growth in a part of the brain called the cerebellum. The cerebellum sits at the back of your skull and controls balance, coordination, and fine movement. In LDD, brain cells in the cerebellum grow in a disorganized, overgrown way, forming a tumor-like mass called a hamartoma. This is not a typical cancerous tumor, but it still takes up space inside the skull and can press on surrounding brain tissue, causing serious symptoms. Most people with LDD also have an underlying condition called Cowden syndrome, which is caused by changes in a gene called PTEN. Cowden syndrome increases the risk of developing certain cancers, including breast, thyroid, and uterine cancer. Because of this connection, a diagnosis of LDD often leads doctors to look for Cowden syndrome and to screen for related cancers. Symptoms of LDD usually appear in adulthood and can include headaches, problems with balance and walking, vision changes, and increased pressure inside the skull. Treatment most often involves surgery to remove as much of the abnormal growth as possible. Unfortunately, the growth can come back after surgery, and there is no medication that cures the disease. Ongoing monitoring and cancer screening are important parts of long-term care.
Also known as:
Key symptoms:
Frequent or worsening headachesDifficulty with balance and coordinationUnsteady or clumsy walking (ataxia)Blurred or double visionNausea and vomitingIncreased pressure inside the skull (raised intracranial pressure)Muscle weakness, especially in the limbsDifficulty swallowingRinging in the ears or hearing changesSeizures in some casesSkin growths or bumps (related to Cowden syndrome)Enlarged head size (macrocephaly)Cognitive or memory difficulties in advanced cases
Clinical phenotype terms (18)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsMersin University
Weill Medical College of Cornell University — NA
Celgene — PHASE1
Providence Medical Technology, Inc. — NA
RxSight, Inc.
Baskent University — NA
American University of Beirut Medical Center — NA
Locate Bio Pty Ltd — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Lhermitte-Duclos disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Lhermitte-Duclos disease at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Lhermitte-Duclos disease.
Community
No community posts yet. Be the first to share your experience with Lhermitte-Duclos disease.
Start the conversation →Latest news about Lhermitte-Duclos disease
Disease timeline:
New recruiting trial: A Post Market Surveillance on INFUSE Bone Graft
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
New recruiting trial: Study on Topping-off Technique for Treating LDD
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
New recruiting trial: AuriculoTherapy NeuroImaging
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
New recruiting trial: A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
New recruiting trial: A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
New recruiting trial: A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
New recruiting trial: Fusion or Not - a Study on Low Back Pain
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
New recruiting trial: LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
New recruiting trial: Total Lumbar Disc Prosthesis and Subsequent Work Activity at at Least Five Years After Total Lumbar Disc Replacement
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
New recruiting trial: Postoperative Scar in the Control Excess of Mobility Induced by Annulus Removal on Inserting a Lumbar Disc Prosthesis
A new clinical trial is recruiting patients for Lhermitte-Duclos disease
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Should I have genetic testing for the PTEN gene, and what does a positive result mean for me and my family?,What cancer screenings do I need because of my diagnosis, and how often should I have them?,What are the signs that the cerebellar growth is coming back, and how often should I have MRI scans?,Is surgery recommended for me right now, and what are the risks and benefits?,Are there any clinical trials or new treatments I should know about for Lhermitte-Duclos disease?,Should my children or siblings be tested for PTEN mutations?,What specialists should be part of my long-term care team?
Common questions about Lhermitte-Duclos disease
What is Lhermitte-Duclos disease?
Lhermitte-Duclos disease (LDD), also known as dysplastic gangliocytoma of the cerebellum or Cowden syndrome with cerebellar involvement, is a rare condition that causes an abnormal growth in a part of the brain called the cerebellum. The cerebellum sits at the back of your skull and controls balance, coordination, and fine movement. In LDD, brain cells in the cerebellum grow in a disorganized, overgrown way, forming a tumor-like mass called a hamartoma. This is not a typical cancerous tumor, but it still takes up space inside the skull and can press on surrounding brain tissue, causing serious
How is Lhermitte-Duclos disease inherited?
Lhermitte-Duclos disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Lhermitte-Duclos disease typically begin?
Typical onset of Lhermitte-Duclos disease is adult. Age of onset can vary across affected individuals.
Which specialists treat Lhermitte-Duclos disease?
1 specialists and care centers treating Lhermitte-Duclos disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.